Long-term Study of Epiduo in Patients With Moderate to Severe Acne
Status:
Completed
Trial end date:
2013-09-01
Target enrollment:
Participant gender:
Summary
This observational study is designed to assess the long-term efficacy and safety of Epiduo
(alone or in combination with other drugs) under daily clinical practice conditions in
patients with moderate to severe inflammatory acne. In addition, the effect of Epiduo on
quality of life and patient adherence will be assessed under marketed conditions.
Details
Lead Sponsor:
Galderma Laboratorium GmbH
Treatments:
Adapalene Adapalene, Benzoyl Peroxide Drug Combination Benzoyl Peroxide